No Data
No Data
Northwest Biotherapeutics | 10-K: FY2024 Annual Report
Express News | Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for up to $50 Million Additional Financing
Press Release: Northwest Biotherapeutics Announces $5 Million Convertible Note Financing and Standby Facility for Up to $50 Million Additional Financing
Northwest Biotherapeutics | 10-Q: Q3 2024 Earnings Report
Northwest Biotherapeutics | 10-Q: Q2 2024 Earnings Report
Northwest Biotherapeutics | 10-Q: Q1 2024 Earnings Report
Moondawgie : pre-approval anticipation
73895873 : same here, I've been looking into it can find any news.
Moondawgie : it’s the old adage - buy the rumor sell the news, however I feel like when the news hits it will push higher